Friday's Analysts' Upgrades, Downgrades

Change in Ratings

Abercrombie & Fitch(ANF Quote) downgraded at JPMorgan from overweight to neutral. Consensus analyst estimates may be too high, as the company lacks potential catalysts to turn same-store sales around.

BlackRock(BLK Quote) downgraded at Goldman to neutral from buy. Cites the stock has essentially reached its target price of $225 and no longer sees favorable risk/reward compared to several peers.

Comverge(COMV Quote) rated new buy at Goldman. Cites company breaking into profitability as its biggest catalyst. Sets $16 target price.

Diamond Offshore(DO Quote) upgraded at JPMorgan from neutral to overweight. Company has the best exposure to U.S. Gulf deepwater demand, and little exposure to international jackups.

Ensco(ESV Quote) downgraded at Citigroup from buy to hold. Latest rig status report shows troubling trends on the international rig side. $77 price target.

General Electric(GE Quote) downgraded at Credit Suisse from outperform to neutral. Company posted poor earnings, on financial services weakness and lower infrastructure margins. Estimates also cut. $41 price target.

Garmin(GRMN Quote) downgraded at Oppenheimer. Rating lowered to perform from outperform. 2008 EPS estimates lowered to $4.03 from $4.68. Price target was removed.

Johnson Controls(JCI Quote) downgraded at JPMorgan from overweight to neutral. Seeing sharply declining leading indicators, which could leader to lower North American automotive demand. Estimates also cut, as currency benefits will only have a minor impact.

MedcoHealth Solutions(MHS Quote) upgraded at Credit Suisse to outperform from neutral. 2008 EPS estimates raised to $2.33 from $2.30. Maintains $58 price target.

Rost Stores(ROST Quote) upgraded at JPMorgan from neutral to overweight. Recent business momentum could continue and drive earnings upside. Company also running on lean inventories, and could use higher free cash flow to buy back more stock.

Valspar(VAL Quote) downgraded at JPMorgan from overweight to neutral. Broad weakness in construction markets could weigh on near-term results. 2008 earnings estimate also trimmed to $1.65 a share.

Stock Comments/EPS Changes

Genentech(DNA Quote) estimates lowered at Jefferies to $3.42 from $3.53. Maintains hold rating and $78 price target.

Johnson & Johnson(JNJ Quote) estimates raised at UBS to $4.46 from $4.43. Maintains buy rating and $77 price target.

Knight Transportation(KNX Quote) numbers lowered at UBS to 71 cents from 87 cents. Price target lowered to $19 from $21. Maintains buy rating.

Kohls(KSS Quote) estimates lowered at Jefferies to $2.95 from $3.15. Maintains $45.50 price target and hold rating.

Target(TGT Quote) numbers lowered at Jefferies. Fiscal 2009 EPS estimates lowered to $3.36 from $3.51. Price target lowered to $52 from $54. Maintains hold rating.

Walmart(WMT Quote) numbers raised at Jefferies. Fiscal 2009 EPS estimates raised to $3.48 from $3.47. Price target raised to $63 from $58. Maintains buy rating.